Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07220200 · ClinicalTrials.gov registry record · NA
MOVE Protocol - Movement-Oriented Velocity of Engagement
A NA study of Musculoskeletal Pain - Acute and Subacute Conditions, sponsored by MMSx Authority Institute for Movement Mechanics and Biomechanics Research.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 4
- Study locations
NCT07220200 is a NA study of Musculoskeletal Pain - Acute and Subacute Conditions that has completed, run by MMSx Authority Institute for Movement Mechanics and Biomechanics Research. The registered enrollment target is 40 participants. The trial reports 4 study locations across 3 states.
The verdict
NCT07220200, a NA study of Musculoskeletal Pain - Acute and Subacute Conditions, has completed, sponsored by MMSx Authority Institute for Movement Mechanics and Biomechanics Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 4
- Study locations
Study Summary
A Prospective, Multi-Site, Interventional Case-Series Evaluating the MOVE (Movement-Oriented Velocity of Engagement) Protocol for Musculoskeletal Pain Recovery
Conditions Studied
Interventions
- BEHAVIORAL MOVE Rehabilitation Protocol
Study Locations (4)
Ohio
- BodyGNTX Fitness Institute - Columbus
- MMSx AUTHORITY (COORDINATING CENTER) - Powell
Madhya Pradesh
- Indian Institute of Kinesiology & Biomechanics Science (IIKBS) - Burhānpur
National Capital Territory of Delhi
- GFFI Fitness Academy - New Delhi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-06-15 |
| Est. Completion | 2025-10-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07220200
The ClinicalTrials.gov registry entry for NCT07220200 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MMSx Authority Institute for Movement Mechanics and Biomechanics Research, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Musculoskeletal Pain - Acute and Subacute Conditions appearing as the primary indexed condition, and to 1 intervention - of which MOVE Rehabilitation Protocol is the first listed.
NCT07220200 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Ohio, Madhya Pradesh, National Capital Territory of Delhi.
Frequently Asked Questions
What is clinical trial NCT07220200 about?
NCT07220200 is a clinical study titled "MOVE Protocol - Movement-Oriented Velocity of Engagement". A Prospective, Multi-Site, Interventional Case-Series Evaluating the MOVE (Movement-Oriented Velocity of Engagement) Protocol for Musculoskeletal Pain Recovery
What is the current status of trial NCT07220200?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2024-06-15. Estimated completion is 2025-10-17.
What conditions does trial NCT07220200 study?
This clinical trial studies the following conditions: Musculoskeletal Pain - Acute and Subacute Conditions.
What interventions are being tested in trial NCT07220200?
The interventions under investigation include: MOVE Rehabilitation Protocol (BEHAVIORAL).
Who is sponsoring clinical trial NCT07220200?
This trial is sponsored by MMSx Authority Institute for Movement Mechanics and Biomechanics Research, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07220200 being conducted?
This trial has 4 study locations across Ohio, Madhya Pradesh, National Capital Territory of Delhi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.